9 stories

If you’ve assumed that biotech companies cluster in Cambridge to be close to Harvard and MIT, that’s only part of the story — other cities were far less welcomin. When a Harvard spin-out, Genetics Institute, tried to set up an office in Somerville in 1981, a public hearing aired concerns about rats and roaches carrying newly invented organisms out of the labs and into a nearby supermarket.More →

Peter Bauer’s e-mail company Mimecast Ltd. got off to a tepid start as a publicly traded company on Wednesday. But the South African-born chief executive, who’s lived in Boston since 2011, seems satisfied with the company’s $78 million haul. “We’re really thrilled to be a public company,” said Bauer. More →

Biogen Idec Inc. is targeting a yet-untreated disease that affects 150,000 Americans while seeking to expand its business of producing drugs for neurological disorders through a deal with a young Cambridge startup.

Cambridge-based Biogen today said it has backed Ataxion, a startup founded a year ago by Cambridge venture capital firm Atlas Venture. Both Biogen and Atlas took part in a $17 million funding deal for the startup, which could also see Ataxion acquired by Biogen if certain milestones are achieved.More →